Latest News about INVA
Recent news which mentions INVA
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
5 Value Stocks To Watch In The Healthcare Sector
June 27, 2022
From Benzinga
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
March 28, 2022
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
1 Healthcare Stock That Could Fly Higher After a Strong Q4
March 05, 2022
From Motley Fool
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 11, 2022
From Benzinga
62 Biggest Movers From Yesterday
February 11, 2022
From Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
From Benzinga
Armata Pharma's Largest Shareholder Injects $45M For Its Bacteriophage Development
February 10, 2022
From Benzinga
From InvestorPlace
10 Stocks to Buy That Could Make You a Millionaire in 2022
January 26, 2022
From InvestorPlace
7 of the Top-Rated Pharmaceutical Stocks for Q1
January 18, 2022
From InvestorPlace
5 Value Stocks In The Healthcare Sector
December 20, 2021
From Benzinga
5 Value Stocks To Watch In The Healthcare Sector
December 06, 2021
From Benzinga
7 Top-Rated Pharmaceutical Stocks To Invest in for October
October 04, 2021
From InvestorPlace
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
5 Value Stocks To Watch In The Healthcare Sector
August 30, 2021
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|